In addition, STAT3 knockdown also inhibited the doxorubicin resistance of BC cells, while further FTO overexpression reversed STAT3 knockdown-induced decreases of doxorubicin resistance of BC cells, suggesting that STAT3 augmented the doxorubicin resistance of BC cells via FTO. This evidence concerns the gene FTO and breast cancer.